WebApr 6, 2024 · According to the issued ratings of 18 analysts in the last year, the consensus rating for CRISPR Therapeutics stock is Hold based on the current 1 sell rating, 8 hold ratings and 9 buy ratings for CRSP. The average twelve-month price prediction for CRISPR Therapeutics is $72.89 with a high price target of $123.00 and a low price target of $39. ... WebClick here to view the most recent quarterly performance reports for the CRSP Market Indexes. Read More. CRSP Total Market. 2,964.43. + 44.78 + 1.53%.
Crispr Therapeutics AG (CRSP) Stock Price & Analysis - TipRanks
WebApr 6, 2024 · ETFs Holding CRSP. Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to … WebCRSP technical analysis. Your technical analysis summary for CRISPR Therapeutics AG. This gauge displays a real-time technical analysis overview for your selected timeframe. … eye surgery for long sightedness
Clinical Research Scholars Prg (CRSP) - Case
WebCRSP technical analysis. Your technical analysis summary for CRISPR Therapeutics AG. This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of CRISPR Therapeutics AG is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. http://web.mit.edu/doncram/www/crsp.html WebFeb 1, 2024 · The Center for Research in Security Prices, LLC (CRSP) maintains the most comprehensive collection of security price, return, and volume data for the NYSE, AMEX and NASDAQ stock markets. Additional CRSP files provide stock indices, beta-based and cap-based portfolios, treasury bond and risk-free rates, mutual funds, and real estate … eye surgery for removing glasses